Efficacy and Safety of Mesenchymal Stem Cell Therapy in Chronic Limb-Threatening Ischemia: A Meta-analysis of Randomized Controlled Trials
Background: Chronic Limb-Threatening Ischemia (CLTI) represents the terminal stage of peripheral artery disease, carrying substantial morbidity and mortality. Despite various therapeutic strategies, clinical outcomes remain unsatisfactory, highlighting the urgent need for novel treatments. While Mesenchymal Stem Cells...